| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $20,897,966 ) (Continued on the next page) |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01DE031272 | Biomimetic and Injectable Highly Porous Nanofiber Microsphere-based Platform for Alveolar Bone Regeneration | 000 | 4 | NIH | 3/6/2026 | $511,798 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01DA060466 | Health Effects of E-cigarette Use on Brain Functions and Cognitive Development among Adolescents: A US Population-Based Study | 000 | 3 | NIH | 1/30/2026 | $330,956 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01DK131990 | Gut bacterial metallophores in the development and severity of inflammatory bowel disease | 000 | 5 | NIH | 2/23/2026 | $622,491 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01HL168500 | Potential mechanism underlying parasympathetic neuronal dysfunction in diabetes | 000 | 3 | NIH | 2/23/2026 | $573,159 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA255618 | Use of radioprotector in rectal cancer | 000 | 5 | NIH | 2/24/2026 | $543,558 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01MH132517 | PREVENTING ALZHEIMER’S DISEASE-LIKE BRAIN PATHOLOGY IN HIV INFECTION BY TARGETING CCR5 | 000 | 4 | NIH | 2/11/2026 | $690,748 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01AR082148 | Effective local delivery of bone anabolic agent to accelerate the healing of delayed fracture union | 000 | 4 | NIH | 12/10/2025 | $396,894 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA295693 | Porcine Platforms For Technology Development In Pancreatic Cancer | 000 | 2 | NIH | 12/9/2025 | $572,175 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | P50AA030407 | Alcohol Center Of Research -- Nebraska (ACORN) | 000 | 4 | NIH | 2/5/2026 | $1,588,725 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | P20GM152326 | Nebraska Center for Heart and Vascular Research | 000 | 3 | NIH | 1/30/2026 | $2,071,512 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA266759 | Nanomedicine of Hedgehog and AKT/ERK Dual Inhibitors for Pancreatic Cancer | 000 | 5 | NIH | 2/10/2026 | $397,901 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA259080 | Preclinical development of a novel antibody conjugate for intraoperative detection of pancreatic cancer | 000 | 5 | NIH | 2/2/2026 | $320,687 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R25AA020818 | Summer Undergraduate Alcohol Research Program | 000 | 14 | NIH | 2/13/2026 | $100,164 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01DA060466 | Health Effects of E-cigarette Use on Brain Functions and Cognitive Development among Adolescents: A US Population-Based Study | 001 | 3 | NIH | 2/6/2026 | $36,774 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01AG092773 | Next Generation Treatment of PAD | 001 | 1 | NIH | 1/28/2026 | -$42,773 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | F30AG076259 | Aberrant cortical entrainment in biomarker-confirmed Alzheimer's disease and mild cognitive impairment | 002 | 6 | NIH | 1/30/2026 | $50,514 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01AI169788 | T cell-innate immune crosstalk regulates Staphylococcus aureus craniotomy infection | 000 | 5 | NIH | 1/23/2026 | $580,813 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R21EY037036 | Using optical sensors to measure synaptic glutamate release from retinal rod photoreceptor cells | 000 | 2 | NIH | 1/23/2026 | $228,913 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01DK135817 | Development and Preclinical Evaluation of Nanoformulations in Liver Fibrotic Mice | 000 | 4 | NIH | 1/27/2026 | $406,078 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01DA059874 | Cannabinoid inhibition of CNS inflammasome activation via modulation of the gut-brain axis | 000 | 2 | NIH | 2/20/2026 | $879,451 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R35GM152032 | DNA Replication Machines: Structure-Function Studies | 000 | 3 | NIH | 1/15/2026 | $455,895 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R61AI188553 | Dose flexible ultra-long-acting prodrug formulations for pediatric populations | 000 | 2 | NIH | 1/14/2026 | $878,122 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R61AI188553 | Dose flexible ultra-long-acting prodrug formulations for pediatric populations | 000 | 2 | NIH | 1/14/2026 | $300,000 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R61AI188553 | Dose flexible ultra-long-acting prodrug formulations for pediatric populations | 000 | 2 | NIH | 1/14/2026 | $250,000 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01AI162964 | Mechanisms of staphylococcal skin colonization | 000 | 5 | NIH | 1/5/2026 | $519,556 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | F30AI186408 | Nitrogen Metabolism of Staphylococcus aureus | 000 | 2 | NIH | 1/8/2026 | $46,138 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01AI163042 | New generation of long acting nucleos(t)ides and immune stimulant for treatment of chronic hepatitis B | 000 | 5 | NIH | 2/10/2026 | $611,174 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01AI168315 | Proteostasis in Plasmodium falciparum artemisinin resistance | 000 | 3 | NIH | 12/10/2025 | $624,631 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA290859 | Lysosome Trapped FAP-Targeted Theranostics for Pancreatic Cancer | 000 | 3 | NIH | 3/5/2026 | $626,716 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01NS134604 | Ionically Conductive Polymeric Biomaterials and Grafts for Nerve Regeneration | 000 | 4 | NIH | 12/18/2025 | $350,987 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105-7835 | DOUGLAS | USA | H7600529 | Ryan White Part C Outpatient EIS Program | 00 | 27 | HRSA | 12/29/2025 | $235,528 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01HL172846 | IL-1R1 in Endothelial-to-Mesenchymal Activation | 000 | 3 | NIH | 2/16/2026 | $433,169 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | F32AA032170 | Negative reinforcement in early abstinence from an alcohol use disorder | 000 | 2 | NIH | 2/18/2026 | $81,592 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01HL171602 | Nrf2 and the exaggerated Exercise Pressor Reflex in Peripheral Arterial Disease | 000 | 3 | NIH | 2/16/2026 | $596,119 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01HL137832 | Mechanisms of cardiac sympathetic hyperactivity in chronic heart failure | 000 | 8 | NIH | 2/23/2026 | $612,814 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01AI145542 | Prodrug Formulations Create Sustained-Release Antiretrovirals | 000 | 7 | NIH | 12/5/2025 | $767,498 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R35GM152032 | DNA Replication Machines: Structure-Function Studies | 001 | 3 | NIH | 3/11/2026 | $506,550 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R35GM152032 | DNA Replication Machines: Structure-Function Studies | 001 | 3 | NIH | 3/11/2026 | -$455,895 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01NS134604 | Ionically Conductive Polymeric Biomaterials and Grafts for Nerve Regeneration | 001 | 4 | NIH | 3/18/2026 | $38,997 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01HL137832 | Mechanisms of cardiac sympathetic hyperactivity in chronic heart failure | 001 | 8 | NIH | 3/19/2026 | $19,352 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | F30AG076259 | Aberrant cortical entrainment in biomarker-confirmed Alzheimer's disease and mild cognitive impairment | 003 | 6 | NIH | 3/24/2026 | $576 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R03CA297351 | Silencing B7-H3 mitigates tumor aggressiveness in group 3 medulloblastoma | 000 | 2 | NIH | 1/21/2026 | $69,075 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01AG092773 | Next Generation Treatment of PAD | 000 | 1 | NIH | 1/22/2026 | $687,071 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01DA062274 | Molecular interplay of HIV Tat, cocaine, and cART in microglial pyroptosis: Role of NLRP3 inflammasome | 000 | 2 | NIH | 1/30/2026 | $448,062 |
| | 2026 | 2026 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R35HL155460 | Harnessing Glycoproteomics and Glycomics to Understand Cardiac Biology and Disease | 000 | 6 | NIH | 3/9/2026 | $729,126 |
| | 2026 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105-7835 | DOUGLAS | USA | U7721499 | Area Health Education Centers Point of Service Maintenance and Enhancement | 02 | 16 | HRSA | 11/28/2025 | $0 |
| | 2026 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA197999 | Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers | 000 | 8 | NIH | 2/23/2026 | -$383,749 |
| | 2026 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01HL155439 | GATA Factor Mechanisms in Erythroid Regeneration | 000 | 5 | NIH | 12/8/2025 | $0 |
| | 2026 | 2025 | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 4215 EMILE ST | OMAHA | NE | 68105 | DOUGLAS | USA | R01CA241752 | Targeting MUC5AC mucin in breast cancer brain metastasis | 000 | 5 | NIH | 11/21/2025 | $0 |
|
